Lonza Walkersville, Inc. and Hyglos GmbH have reached a global settlement that includes a license agreement for Hyglos under certain Lonza patents in the area of endotoxin detection. The agreement allows Hyglos to use recombinant factor C technology under Lonza’s patents to produce Hyglos’ endotoxin products. The agreement dismisses the lawsuit Lonza previously filed against Hyglos. Financial terms were not disclosed.   “Thanks to this agreement an important door has opened for a new era in endo...